Shigella is a diarrheal pathogen that causes disease through invasion of th
e large intestinal mucosa, The endotoxin of the invading bacterium may play
a key role in the disease process by causing inflammation and tissue injur
y during infection. Earlier studies have shown that various animal species
lacking functional CD14 were protected against endotoxin-mediated shock. Ra
bbits experimentally infected with Shigella were used to test the hypothesi
s that blockade of endotoxin-induced cell activation with anti-CD14 mAb wou
ld diminish inflammation and thus disease severity. Unexpectedly, we observ
ed that the intestinal mucosa of anti-CD14-treated animals exhibited a 50-f
old increase in bacterial invasion and more severe tissue injury compared w
ith controls. Despite higher bacterial loads in treated animals, the number
s of polymorphonuclear leukocytes that were recruited to the infection site
were similar to those in controls. Furthermore, the phagocytic cells of CD
14-blocked animals produced IL-1 and TNF-alpha, Moreover, in vitro blockade
of CD14 did not impede bactericidal activity. Thus, anti-CD14 treatment in
terfered with host defense mechanisms involved with removal/eradication of
Shigella.